Chemoinformaics analysis of (-)-Zingiberene
| Molecular Weight | 204.357 | nRot | 4 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 7 |
| Exact Molecular Weight | 204.188 | nRing | 1 |
| Solubility: LogS | -5.662 | nHRing | 0 |
| Solubility: LogP | 5.679 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.572 |
| Synth | 3.917 |
| Natural Product Likeliness | 3.202 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.239 |
| Pgp-sub | 0.002 |
| HIA | 0.012 |
| CACO-2 | -4.53 |
| MDCK | 0.0000139 |
| BBB | 0.415 |
| PPB | 0.976821 |
| VDSS | 5.369 |
| FU | 0.0291719 |
| CYP1A2-inh | 0.646 |
| CYP1A2-sub | 0.691 |
| CYP2c19-inh | 0.459 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.406 |
| CYP2c9-sub | 0.783 |
| CYP2d6-inh | 0.314 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.742 |
| CYP3a4-sub | 0.477 |
| CL | 16.272 |
| T12 | 0.228 |
| hERG | 0.072 |
| Ames | 0.008 |
| ROA | 0.022 |
| SkinSen | 0.963 |
| Carcinogencity | 0.108 |
| EI | 0.845 |
| Respiratory | 0.45 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.80714 |